On Monday, when markets opened, Regeneron stock prices surged from $564 to over $600 a share. That day, Joseph Goldstein, who sits on the company’s board of directors, and SVP and Head of Commercial Marion McCourt exercised stock options that let them sell a total of 10,200 shares for a net profit of over $1 million. According to filings, that netted about $740,000 for Goldstein and $260,000 for McCourt.
...The New York Times reported that Trump’s financial documents reveal the president’s three family trusts held investments in Regeneron as well as pharmaceutical giant Sanofi, which itself is a major shareholder in Regeneron.
I obsess about obsession because it seems like the best use of the pathology.
Not that I really have any choice...
I believe that the majority of mental illness is secondary symptoms of common chronic infections. I was a medical librarian, and now I just pretty much constantly research sleep disorders, depression, mania and dementia. This is where I collect my accumulating hypotheses and try to document the atrocities occurring daily in the Infection Industrial Complex.
My goal is not to convince you that my ideas are right, but to show you there is more than one way to interpret scientific data.
Update: After fifteen years of this, I finally think I am right.
